Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) has issued an update.
Jiangxi Rimag Group Co., Ltd. has announced a strategic collaboration with Beijing Rimag Sunshine Medical Information Technology Co Ltd., Beijing Data Pioneer Zone Service Co., Ltd., and Beijing International Computing Power Service Co., Ltd. to establish a high-quality medical imaging database. This partnership, leveraging the Beijing Artificial Intelligence Data Sandbox, aims to transform the company’s data assets into marketable products, marking a significant breakthrough with the successful execution of a RMB10 million contract. The initiative aligns with national policies on data element marketization and is expected to bolster the company’s business development and competitive edge in the AI-based medical imaging sector.
The most recent analyst rating on (HK:2522) stock is a Hold with a HK$16.00 price target. To see the full list of analyst forecasts on Jiangxi Rimag Group Co., Ltd. Class H stock, see the HK:2522 Stock Forecast page.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on AI-based medical imaging. The company, along with its subsidiaries, is involved in the data business sector, aiming to enhance its competitiveness through strategic collaborations.
Average Trading Volume: 19,716,978
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.99B
See more insights into 2522 stock on TipRanks’ Stock Analysis page.